Items in cart [1] Questions? Call 888-624-8373

PAPERBACK list:$22.00 Web:$19.80 add to cart PDF BOOK your price: $17.00 add to cart Rights & Permissions Free Resources PDF EXECUTIVE SUMMARY Display this book on your site! Related Titles From Cancer Patient to Cancer Survivor: Lost in Transition The Learning Healthcare System: Workshop Summary (IOM Roundtable on Evidence-Based Medicine) Other Related Titles The Role of Purchasers and Payers in the Clinical Research Enterprise: Workshop Summary (2002) Institute of Medicine (IOM) Web Search Builder Use this book's key terms to search within this book, across our collection, or across the Web. Skim This Chapter Skim this chapter and use this chapter's key terms to search within this book. Reference Finder Paste in your own text to find books that relate to your topic. Page 97   E-mail  Facebook  Digg  Stumble  Twitter More The following HTML text is provided to enhance online readability. Many aspects of typography translate only awkwardly to HTML. Please use the page image as the authoritative form to ensure accuracy. Appendix IV Workshop Agenda DECEMBER 12, 2001 Park Hyatt Hotel, Washington, DC Park Hyatt Ballroom 8:30 am Welcoming Remarks and Meeting Objectives   Clinical Research Roundtable Co-Chairs   Enriqueta Bond, Ph.D. President Burroughs Welcome Fund   William Gerberding, Ph.D. President Emeritus University of Washington   Workshop Co-Chairs   Allan Korn, M.D. Senior Vice President and Chief Medical Officer Blue Cross Blue Shield Association   Sean Tunis, M.D., M.Sc. Director, Coverage and Analysis Group Office of Clinical Standards and Quality Centers for Medicare and Medicaid Services 9:00 Purchaser Perspective   Each speaker has been asked to present a brief 5 min. overview of their responses to the two broad questions. Page 97 Front Matter (R1-R14) Workshop Summary (1-4) Introduction to the Workshop (5-8) 1 The Role of Purchasers in the Clinical Research Enterprise (9-28) 2 The Role of Payers in the Clinical Research Enterprise (29-50) 3 The Role of Other Stakeholders in the Clinical Research Enterprise (51-69) 4 Opportunities and Challenges in the Clinical Research Enterprise (70-81) Suggested Readings (82-82) Appendix I: Speaker Biographies (83-89) Appendix II: Speaker's Company Profiles (90-93) Appendix III: Purchaser Payer Background Information (94-96) Appendix IV: Workshop Agenda (97-100) Appendix V: Definitions of Clinical Research and Components of the Enterprise (101-102) Appendix VI: Registered Workshop Participants (103-106)

Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.

OCR for page 97
Appendix IV Workshop Agenda DECEMBER 12, 2001 Park Hyatt Hotel, Washington, DC Park Hyatt Ballroom 8:30 am Welcoming Remarks and Meeting Objectives   Clinical Research Roundtable Co-Chairs   Enriqueta Bond, Ph.D. President Burroughs Welcome Fund   William Gerberding, Ph.D. President Emeritus University of Washington   Workshop Co-Chairs   Allan Korn, M.D. Senior Vice President and Chief Medical Officer Blue Cross Blue Shield Association   Sean Tunis, M.D., M.Sc. Director, Coverage and Analysis Group Office of Clinical Standards and Quality Centers for Medicare and Medicaid Services 9:00 Purchaser Perspective   Each speaker has been asked to present a brief 5 min. overview of their responses to the two broad questions.

OCR for page 98
  Moderator—Patricia Salber MD, General Motors Jill Berger Corporate Health and Welfare Manager Marriot Helen Darling President Washington Business Group on Health Bruce Taylor Director National Health Care & Policy Plans Verizon Dale Whitney Corporate Health and Welfare Manager United Parcel Service Gregg Lehman President & CEO National Business Coalition on Health Jon Hautz Senior Consultant William M. Mercer Inc. 9:30 Clinical Research Roundtable Discussion 10:15 Questions and Comments from the Audience 10:30 Break 10:45 Payer & Health System Perspective   Each speaker has been asked to present a brief 5 min. overview of their responses to the two broad questions.   Moderators—Alan Korn, Blue Cross Blue Shield Association and Sean Tunis, Centers for Medicare and Medicaid Services Eric Book, MD Chief Medical Officer Wellmark Reed Tuckson, MD Chief Medical Officer United Healthgroup Robert McDonough, MD Medical Director for Quality Management Aetna George Isham, MD Medical Director and Chief Health Officer HealthPartners Chuck Cutler, MD Chief Medical Officer American Association of Health Plans

OCR for page 99
11:15 Clinical Research Roundtable Discussion 12:00 Questions and Comments from the Audience 12:15 pm Lunch (for members and guests in the meeting room) 1:15 Stakeholder Perspective   Please respond to the issues raised in the first two panels. What are your needs? What is your role? What can you contribute to the Clinical Research Enterprise?   Moderator—Myrl Weinberg, President, National Health Council Francis Chesley, MD Director, Office of Research, Review, Education and Policy Agency for Healthcare, Research & Quality Susan Foote, JD Board Member, Medical Technology Leadership Forum Dennis Scanlon, Ph.D. Associate Professor, Health Policy and Administration Pennsylvania State University Robert M. Califf, MD Division of Cardiology, Department of Medicine Duke University John H. Graham IV Chief Executive Officer American Diabetes Association John Stevens, MD Vice President for Extramural Grants Research Department American Cancer Society 1:45 Clinical Research Roundtable Discussion 2:30 Questions and Comments from the Audience 2:45 Break 3:00 Roundtable Discussion: Opportunities and challenges   This two-hour discussion regarding opportunities and challenges for the Clinical Research Enterprise will begin with a 20-minute presentation by Dr. Lou Sherwood. Audience participation is wel come.

OCR for page 100
  Moderators—Allan Korn, BCBSA and Sean Tunis, CMS   “The Second Frontier” – Lou Sherwood, M.D. Senior Vice President for Medical and Scientific Affairs Merck and Company 5:00 Concluding Remarks   Enriqueta Bond, Ph.D. President Burroughs-Welcome Fund   William Gerberding, Ph.D. President Emeritus University of Washington

Representative terms from entire chapter:

research roundtable